Leerink Partners Adds Asthika Goonewardene as Senior Managing Director in Oncology Research

Leerink Partners has expanded its oncology research capabilities by hiring Asthika Goonewardene, a senior biotechnology analyst with nearly two decades of experience. He joins from Truist Securities and will focus on publicly traded oncology companies and emerging therapeutic technologies.

By Leerink Partners · PR Newswire ·

Topics: biotechnology healthcare oncology

Read the full article at PR Newswire

More World news